[{"address1": "7800 Susquehanna St.", "address2": "Suite 505", "city": "Pittsburgh", "state": "PA", "zip": "15208", "country": "United States", "phone": "412 894 1853", "website": "https://lipella.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It develops LP-10, a formulation of tacrolimus for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; LP-410, an oral liposomal formulation of tacrolimus to treat oral graft-versus-host disease; and LP-50, an intravesical formulation of immunoglobulins for the treatment of non-muscle invasive bladder cancer. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jonathan  Kaufman M.B.A., Ph.D.", "age": 57, "title": "Co-Founder, Chairman, CEO, President, Secretary & Treasurer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 233300, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael B. Chancellor M.D.", "age": 66, "title": "Co-Founder, Chief Medical Officer & Director", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 225000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Douglas  Johnston CPA", "age": 39, "title": "Chief Financial Officer", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 165000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Michele  Gruber", "title": "Director of Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Janet  Okonski", "title": "Director of Clinical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Katie  Johnston", "title": "Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.56, "open": 0.56, "dayLow": 0.56, "dayHigh": 0.56, "regularMarketPreviousClose": 0.56, "regularMarketOpen": 0.56, "regularMarketDayLow": 0.56, "regularMarketDayHigh": 0.56, "payoutRatio": 0.0, "beta": -0.053, "forwardPE": -0.175, "volume": 37, "regularMarketVolume": 37, "averageVolume": 5671, "averageVolume10days": 3430, "averageDailyVolume10Day": 3430, "bid": 0.56, "ask": 0.6, "bidSize": 8981, "askSize": 33000, "marketCap": 2587669, "fiftyTwoWeekLow": 0.53, "fiftyTwoWeekHigh": 7.31, "allTimeHigh": 61.76, "allTimeLow": 0.53, "priceToSalesTrailing12Months": 5.50377, "fiftyDayAverage": 0.61686, "twoHundredDayAverage": 2.003015, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 80395, "profitMargins": 0.0, "floatShares": 4329355, "sharesOutstanding": 4620837, "sharesShort": 100093, "sharesShortPriorMonth": 133447, "sharesShortPreviousMonthDate": 1745971200, "dateShortInterest": 1748563200, "sharesPercentSharesOut": 0.0224, "heldPercentInsiders": 0.06525, "heldPercentInstitutions": 0.0135, "shortRatio": 3.32, "shortPercentOfFloat": 0.0235, "impliedSharesOutstanding": 4620838, "bookValue": 0.614, "priceToBook": 0.9120521, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -5520318, "trailingEps": -3.33, "forwardEps": -3.2, "lastSplitFactor": "1:8", "lastSplitDate": 1731024000, "enterpriseToRevenue": 0.171, "enterpriseToEbitda": -0.014, "52WeekChange": -0.8267327, "SandP52WeekChange": 0.17904854, "quoteType": "EQUITY", "currentPrice": 0.56, "recommendationKey": "none", "totalCash": 2781828, "totalCashPerShare": 0.602, "ebitda": -5592217, "totalDebt": 274539, "quickRatio": 3.781, "currentRatio": 4.602, "totalRevenue": 470163, "debtToEquity": 10.014, "revenuePerShare": 0.216, "returnOnAssets": -1.18454, "returnOnEquity": -2.4835699, "grossProfits": -3423922, "freeCashflow": -2477698, "operatingCashflow": -4502780, "revenueGrowth": -0.364, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -15.641899, "financialCurrency": "USD", "symbol": "LIPO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "corporateActions": [], "regularMarketTime": 1759449600, "marketState": "CLOSED", "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.56, "exchange": "PNK", "messageBoardId": "finmb_35907207", "exchangeTimezoneName": "America/New_York", "epsTrailingTwelveMonths": -3.33, "epsForward": -3.2, "fiftyDayAverageChange": -0.05685997, "fiftyDayAverageChangePercent": -0.09217646, "twoHundredDayAverageChange": -1.4430151, "twoHundredDayAverageChangePercent": -0.7204215, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2022-12-20", "cryptoTradeable": false, "fullExchangeName": "OTC Markets OTCPK", "shortName": "Lipella Pharmaceuticals Inc.", "longName": "Lipella Pharmaceuticals Inc.", "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1671460200000, "regularMarketChange": 0.0, "regularMarketDayRange": "0.56 - 0.56", "averageDailyVolume3Month": 5671, "fiftyTwoWeekLowChange": 0.030000031, "fiftyTwoWeekLowChangePercent": 0.056603834, "fiftyTwoWeekRange": "0.53 - 7.31", "fiftyTwoWeekHighChange": -6.75, "fiftyTwoWeekHighChangePercent": -0.9233926, "fiftyTwoWeekChangePercent": -82.67327, "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Lipella Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-10-04"}]